info@seagull-health.com
SeagullHealth
语言:
search

Before taking Emflaza(Deflazacort)

This part details important safety information and conditions requiring special attention during treatment.

Important Safety Information

Caution is advised due to numerous potential risks. EMFLAZA can cause hypothalamic-pituitary-adrenal axis suppression, hyperglycemia, and Cushing's syndrome. It suppresses the immune system, increasing susceptibility to infections and reactivating latent ones. Patients should be monitored for hypertension, electrolyte imbalances, and gastrointestinal issues. Behavioral and mood disturbances, as well as negative effects on bone health and growth in children, are significant concerns that require monitoring.

Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved